Recipharm and LIDDS establish manufacturing capabilities for prostate cancer product
Recipharm, a contract development and manufacturing organisation and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden